Diagnostic Criteria OF Classical Carcinoids

References

• Obendorfer S. Karcinoide Tumoren des Diinndarms. Pathol (Frankfurt) 1907; 1: 426–32
   Google Scholar
• Lembeck F. 5-hydroxytryptamine in a carcinoid tumor. Nature 1953; 172: 910–1
   Web of Science ®Google Scholar
• Thorson AH. Studies on carcinoid disease. Acta Med Scand 1958; 161: 132, Suppl 334
   Google Scholar
• Williams E D, Sandler M. The classification of carcinoid tumors. Lancet 1963; 1: 283–239
   PubMed Web of Science ®Google Scholar
• Singh I. A modification of the Masson-Hamperl method for staining of argentaffin cells. Anat Anz 1964; 114: 81–2
   Google Scholar
• Grimelius L. A silver nitrate stain for α2-cells in human pancreatic islets. Acta Soc Med Upsal 1968; 73: 243–70
   PubMedGoogle Scholar
• Grimelius L, Wilander E. Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol 1980; 3: 3–12
   PubMedGoogle Scholar
• Soga J, Krenji T. Pathologic analysis of carcinoids. Cancer 1971; 28: 990–8
   PubMed Web of Science ®Google Scholar
• Nash S V, Said JW. Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chro-mogranin) markers in foregut, midgut and hindgut tumors. J Clin Pathol 1986; 86: 415–22
   Web of Science ®Google Scholar
• Moll R, Franke WW. Cytoskeletal differences between human neuroendocrine tumors: a cytoskeletal protein of molecular weight 46 000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation 1985; 30: 165–75
   PubMed Web of Science ®Google Scholar
• Hoefler H, Denk H, Lackinger E, et al. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuroendocrine tumors). Virchows Arch (A) 1986; 409: 609–26
   Web of Science ®Google Scholar
• Pinkus G S, Etheridge C L, O'Connor EM. Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. Am J Clin Pathol 1986; 85: 269–77
   PubMed Web of Science ®Google Scholar
• Azzopardi J G, Pollock DJ. Argentaffin and argyrophil cells in gastric carcinoma. J Pathol Bacteriol 1963; 86: 443–7
   PubMedGoogle Scholar
• Eusebi V, Capella C, Bordi A, Sessa F, Vezzadini P, Mancini AM. Endocrine-paracrine cells in pancreatic exocrine carcinomas. Histopathology 1981; 5: 599–613
   PubMed Web of Science ®Google Scholar
• Partanen S, Syrjänen K. Argyrophil cells in carcinoma of the female breast. Virchows Arch (A) 1981; 391: 45–51
   PubMed Web of Science ®Google Scholar
• Lunqvist M, Wilander E. Exocrine and endocrine cell differentiation in small intestinal adenocarcinomas. Acta Pathol Microbiol Immunol Scand 1983; 91: 469–74
   Google Scholar
• Gosset A, Masson P. Tumeurs endocrine de l'appendice. Presse Med 1914; 25: 237
   Google Scholar
• Barter R, Pearse A GE. Detection of 5-hydroxy-tryptamine in mammalian enterochromaffin cells. Nature 1953; 171: 810
   Google Scholar
• Lundqvist M, Wilander E. Small intestinal chromaffin cells and carcinoid tumors; a study with silver stains, formalin-induced fluorescence and monoclonal antibodies to serotonin. Histochem J 1984; 16: 1247–56
   PubMedGoogle Scholar
• Lundqvist M, Wilander E. Majority and minority cell populations in small intestinal carcinoids. Acta Pathol Microbiol Immunol Scand (Sect A) 1982; 90: 317–21
   PubMedGoogle Scholar
• Rindi G, Buffa R, Sessa T, Tortora O, Solcia E. Chromogranin A, B, and C immunoreactivities of mammalian endocrine cells. Distribution and distinction from costored hormones/prohor-mones and relationship with the argyrophil component of secretory granules. Histochemistry 1986; 85: 19–28
   PubMedGoogle Scholar
• Wilander E. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumours. Acta Oncol 1989; 28: 363–9
   PubMed Web of Science ®Google Scholar
• Pinkus G S, Kurtin PJ. Epithelial membrane antigen—a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial mesenchymal and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Human Pathol 1985; 16: 929–40
   PubMed Web of Science ®Google Scholar